Ryaltris

Glenmark Pharmaceuticals Inc., USA🇺🇸 United States

FDA Page

Effective Date: Jul 21, 2026
Approval ID: 406be932-f00e-4c66-9dd1-c142090fe822
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RYALTRIS safely and effectively. See full prescribing information for RYALTRIS. RYALTRIS (olopatadine hydrochloride and mometasone furoate monohydrate nasal spray)Initial U.S. Approval: 2022

Quick Stats

Total Products1

Labelers1

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.